Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

Products Containing Highly Unsaturated Fatty Acids for Use by Women and Their Children During Stages of Preconception, Pregnancy and Lactation/Post-Partum

a technology products, applied in the field of maternal and child nutritional supplements, can solve the problems of continuing controversy over the use of unsaturated fatty acids in infant formulas, and many have failed to demonstrate significant benefits, so as to improve the quality of eggs, improve cognitive outcomes, and improve the effect of fetal weight gain

Inactive Publication Date: 2013-08-01
DSM IP ASSETS BV
View PDF3 Cites 4 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Benefits of technology

The present invention relates to a nutritional supplementation scheme for infants and pregnant women that includes DHA and DPA(n-6). The invention aims to provide a balance of ARA to support placental and fetal growth, while avoiding the depression of ARA by DHA. The use of a nutritional supplementation scheme that does not result in the depression of ARA and the need for replenishment is a desirable advantage of the invention. The supplementation scheme can promote the accumulation of ARA in tissues and enhance cognitive outcomes, fetal weight gain, and pre-term delivery. The invention also provides benefits for breastfeeding mothers and infants through maternal breast milk or infant formula and food supplementation.

Problems solved by technology

Several studies have documented similar benefits to full-term infants fed ARA / DHA, however, several have failed to demonstrate any significant benefits.
Due at least in part to these conflicting data, controversy about the use of these fatty acids in infant formulas continues.

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Examples

Experimental program
Comparison scheme
Effect test

example 1

[0104]Preconception formula containing 200 mg of ARA and 100 mg of DHA, combined with 300 mg of calcium, 100 mcg of folic acid, 200 IU Vitamin D, 150 mg magnesium. 300 mg phosphorus, 25 mcg Vitamin K, 2 mcg B12, and 50% of the DV for each of niacin, thiamine, riboflavin, biotin and B6.

example 2

[0105]First trimester formula containing 200 mg of ARA and 100 mg of DHA, combined with 300 mg of calcium, 100 mcg of folic acid, 200 IU Vitamin D, 150 mg magnesium, 300 mg phosphorus, 25 mcg Vitamin K, 2 mcg B12, and 50% of the DV for each of niacin, thiamine, riboflavin, biotin and B6 and ginger to ease morning sickness.

example 3

[0106]Second trimester formula containing 100 mg ARA and 100 mg of DHA, combined with 300 mg of calcium, 100 mcg of folic acid, 200 IU Vitamin D, 150 mg magnesium, 300 mg phosphorus, 25 mcg Vitamin K, 2 mcg B12, and 50% of the DV for each of niacin, thiamine, riboflavin, biotin and B6.

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

A method and product for improving maternal and child health through nutrition. Omega-6 fatty acid and / or omega-3 fatty acid are provided to a woman and / or child prior to, during and / or after pregnancy to improve the health of the woman and her child. The ratios of the omega-6 and omega-3 fatty acids vary during various stages, e.g., pre-pregnancy, pregnancy and post-pregnancy. The omega-6 and omega-3 fatty acids can be in a variety of forms, such as at least one of highly purified algal oil comprising 70% by weight or more of the desired HUFA, triglyceride oil combined with phospholipid, phospholipid, protein and phospholipid combination, or dried marine microalgae.

Description

BACKGROUND OF THE INVENTION[0001]1. Field of the Invention[0002]The present invention is directed to maternal and child nutritional supplements, and in particular maternal and child nutritional supplements that include at least one omega-6 highly unsaturated fatty acid (HUFA) and at least one omega-3 HUFA in certain desired ratios. The ratios of omega-6 HUFA:omega-3 HUFA recommended during various stages vary, for example, the ratios of omega-6 HUFA:omega-3 HUFA can vary between stages of preconception, pregnancy and lactation / postpartum.[0003]2. Background Art[0004]Currently the scientific literature suggests supplementation with the omega-6 HUFA arachidonic acid (ARA) and the omega-3 HUFA docosahexaenoic acid (DHA) is important for pre-term infant growth and development. Pre-term infants provided with ARA / DHA either from breast milk or enriched infant formula demonstrate improved cognitive abilities, including better vocabulary development, memory, and problem-solving skills, than...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Applications(United States)
IPC IPC(8): A23L1/30A23L33/00A61K31/202
CPCA61K31/202A23L1/3008G06Q90/00A23L1/293A23V2002/00A23D9/00A23L33/30A23L33/12
Inventor VAN ELSWYK, MARY
Owner DSM IP ASSETS BV
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products